Prevest Denpro Limited Announces Director Cessation Upon Completion of Tenure
Prevest Denpro Limited announced that Mr. Pardeep Gandotra (DIN: 08733719) ceased as Independent Director on April 26, 2026, upon completion of his tenure. The company filed the required regulatory disclosure under SEBI Listing Regulations on April 27, 2026, with Managing Director Atul Modi signing the notification.

*this image is generated using AI for illustrative purposes only.
Prevest denpro Limited has announced a change in its board composition with the cessation of an Independent Director upon completion of tenure. The company filed the necessary regulatory disclosure on April 27, 2026, informing the stock exchanges about this scheduled board change.
Director Cessation Details
Mr. Pardeep Gandotra (DIN: 08733719) ceased to hold office as Independent Director of the company effective from the closure of business hours on April 26, 2026. The cessation occurred due to the natural completion of his tenure as an Independent Director, marking the end of his scheduled term with the company.
| Parameter: | Details |
|---|---|
| Director Name: | Mr. Pardeep Gandotra |
| DIN: | 08733719 |
| Position: | Independent Director |
| Reason for Change: | Completion of tenure |
| Effective Date: | April 26, 2026 (closure of business hours) |
Regulatory Compliance
The company fulfilled its regulatory obligations by filing the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in accordance with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Managing Director Atul Modi (DIN: 00788272) signed the disclosure document on behalf of Prevest Denpro Limited. The company has also committed to making this information available on its official website for stakeholder reference.
Corporate Governance Impact
The cessation represents a routine board transition as Independent Directors serve fixed terms under corporate governance norms. The completion of Mr. Gandotra's tenure follows the standard practice of Independent Director appointments, which are subject to specific tenure limits as per regulatory requirements.
Who will Prevest Denpro appoint as the new Independent Director to fill the vacancy left by Mr. Gandotra's departure?
How might this board transition impact Prevest Denpro's strategic decision-making and corporate governance practices in the coming quarters?
Will the company face any challenges in maintaining board independence ratios required under SEBI regulations following this cessation?
































